QURE News

UNIQURE N.V. (QURE) DEADLINE ALERT Bernstein Liebhard LLP Reminds uniQure N.V. Investors of Upcoming Deadline

QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm

Class Action Filed Against uniQure N.V. (QURE) Seeking Recovery for Investors - Contact The Gross Law Firm

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against uniQure N.V.

QURE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that uniQure N.V. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!

uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

ROSEN, TOP RANKED TRIAL LAWYERS, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QURE

Pomerantz LLP Highlights Legal Filing Against uniQure N.V. – QURE

uniQure N.V. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 13, 2026 to Discuss Your Rights – QURE

uniQure N.V. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 13, 2026 to Discuss Your Rights – QURE